Development of small molecules that inhibit protein kinases in vivo are currently one of the most aggressively pursued areas of drug discovery as there are many kinases that are implicated in the pathology of cancers, cardiac, and CNS diseases, yet this field is in its infancy in molecular imaging. Here, WEE1 is linked to cancer.